Early Stage companies chosen to present at this year’s Forum are:
Achelios Therapeutics is a clinical-stage specialty pharmaceutical company developing proprietary topical formulations of non-steroidal anti-inflammatory drug (NSAID) molecules to treat pain and inflammation.
AMPEL Biosolutions is a technology company with CRO capabilities combining genomic technologies with advanced analytics to develop the Clinical Genomic Blood Test to match patients to the best therapy in clinical trials and clinical care.
Ares Immunotherapy is a pre-clinical adoptive T cell therapy company based on technology discovered at the Medical University of South Carolina developing CD26+ CAR-T cells therapy specific for mesothelin for the treatment of mesothelioma and other solid tumors.
Azure 8 (Atlanta, GA)
Azure 8 is a medical device company developing the Sonix-A8TM, a Class II medical device to prevent and control surgical site and catheter-related bacterial infections.
Cathaid is a medical device company developing CathaidTM, a Class I medical device to better secure central venous catheters which allows real time detection of dangerous positional shifts and reduces infection.
Dermasensor is a medical device company developing a handheld wireless medical device for dermatologists that uses electron scattering microscopy combined with a proprietary algorithm to evaluate skin lesions for potential skin cancer.
EDP Biotech is an ISO-certified in vitro diagnostics company focused on the commercialization of ColoPlex™, a blood-based test aimed at early detection of colorectal cancer.
Evren Technologies is a medical device company based on technology discovered at the University of Florida that is developing the PhoenixTM, a wearable device that provides transcutaneous vagal nerve stimulation for the treatment of post-traumatic stress disorder.
IMMvention Therapeutix (Durham, NC)
IMMvention Therapeutix is a drug discovery start-up based on technology discovered at the University of North Carolina, Chapel Hill that is developing a pre-clinical pipeline of proprietary innate immunity specific therapies for autoimmune and inflammatory diseases.
Inquisatex Epitherapeutics is a drug discovery start-up based on technology discovered at the Medical University of South Carolina developing a novel series of compounds for the treatment of Sickle Cell Disease.
KeViRx (Charlottesville, VA)
KeViRx is a pre-clinical oncology company based on technology discovered at the University of Virginia and the University of Pittsburgh developing KVR-053, an allosteric PTP4A3 phosphatase small molecule inhibitor for ovarian, colorectal and breast cancers.
Oracle Health (Tampa, FL)
Oracle Health is a medical device company developing a Digital Health enabled Insertable Cardiac Monitor (ICM) to follow Heart Failure progression and prevent Heart Failure hospitalization.
Oxidien Pharmaceuticals is a clinical stage drug development company with proprietary enzyme assets to treat hyperoxaluria, a severe and debilitating condition causing renal damage, progressive chronic kidney disease, and end-stage renal failure.
Park Surgical Innovations (Atlanta, GA)
Park Surgical Innovations is a medical device company developing the Park Surgical Graft Delivery System, a class II medical device and method for delivering a prosthetic graft for laparoscopic ventral hernia repair.
Plakous Therapeutics is a pre-clinical regenerative medicine company developing Protego-PD™, an acellular placental derived platform product for the treatment of necrotizing enterocolitis (NEC) and osteoarthritis (OA).
Pyrefin, Inc. (Atlanta, GA)
Pyrefin, Inc. is a pre-clinical drug discovery company based on technology discovered at Emory University developing orally-active small molecule antagonists of the prostaglandin E2 (EP2) receptor for the treatment of pain and inflammation.